Vanguard Group
ERNA icon

Vanguard Group’s Eterna Therapeutics ERNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,190
Closed -$6.8K 4292
2025
Q1
$6.8K Buy
38,190
+12,091
+46% +$2.15K ﹤0.01% 4265
2024
Q4
$7.67K Hold
26,099
﹤0.01% 4285
2024
Q3
$27.4K Hold
26,099
﹤0.01% 4282
2024
Q2
$47.8K Hold
26,099
﹤0.01% 4295
2024
Q1
$62.6K Hold
26,099
﹤0.01% 4289
2023
Q4
$46.8K Buy
26,099
+1,201
+5% +$2.16K ﹤0.01% 4378
2023
Q3
$54.3K Buy
24,898
+5,830
+31% +$12.7K ﹤0.01% 4405
2023
Q2
$43.1K Hold
19,068
﹤0.01% 4473
2023
Q1
$64.8K Sell
19,068
-10,000
-34% -$34K ﹤0.01% 4445
2022
Q4
$93.6K Sell
29,068
-858,160
-97% -$2.76M ﹤0.01% 4401
2022
Q3
$220K Sell
887,228
-253,642
-22% -$62.9K ﹤0.01% 4399
2022
Q2
$590K Sell
1,140,870
-148,121
-11% -$76.6K ﹤0.01% 4246
2022
Q1
$2.64M Sell
1,288,991
-21,499
-2% -$44.1K ﹤0.01% 3840
2021
Q4
$5.47M Buy
1,310,490
+766,651
+141% +$3.2M ﹤0.01% 3557
2021
Q3
$5.06M Buy
543,839
+134,741
+33% +$1.25M ﹤0.01% 3655
2021
Q2
$7.37M Buy
+409,098
New +$7.37M ﹤0.01% 3374
2021
Q1
Sell
-16,227
Closed -$36K 4335
2020
Q4
$36K Hold
16,227
﹤0.01% 4190
2020
Q3
$28K Hold
16,227
﹤0.01% 4086
2020
Q2
$36K Hold
16,227
﹤0.01% 4041
2020
Q1
$25K Hold
16,227
﹤0.01% 4036
2019
Q4
$36K Hold
16,227
﹤0.01% 4060
2019
Q3
$55K Hold
16,227
﹤0.01% 4077
2019
Q2
$62K Hold
16,227
﹤0.01% 4087
2019
Q1
$65K Hold
16,227
﹤0.01% 4044
2018
Q4
$32K Sell
16,227
-5,042
-24% -$9.94K ﹤0.01% 4100
2018
Q3
$95K Hold
21,269
﹤0.01% 4081
2018
Q2
$94K Buy
21,269
+100
+0.5% +$442 ﹤0.01% 4056
2018
Q1
$144K Buy
21,169
+4,235
+25% +$28.8K ﹤0.01% 3995
2017
Q4
$71K Sell
16,934
-676
-4% -$2.83K ﹤0.01% 4020
2017
Q3
$108K Hold
17,610
﹤0.01% 3981
2017
Q2
$120K Buy
17,610
+3,606
+26% +$24.6K ﹤0.01% 3975
2017
Q1
$120K Buy
14,004
+500
+4% +$4.28K ﹤0.01% 3974
2016
Q4
$115K Buy
13,504
+100
+0.7% +$852 ﹤0.01% 3965
2016
Q3
$92K Sell
13,404
-3,246
-19% -$22.3K ﹤0.01% 3986
2016
Q2
$143K Sell
16,650
-644,525
-97% -$5.54M ﹤0.01% 3985
2016
Q1
$99K Hold
661,175
﹤0.01% 4028
2015
Q4
$106K Buy
661,175
+6,200
+0.9% +$994 ﹤0.01% 4074
2015
Q3
$210K Buy
654,975
+800
+0.1% +$256 ﹤0.01% 4024
2015
Q2
$152K Buy
654,175
+4,400
+0.7% +$1.02K ﹤0.01% 4081
2015
Q1
$273K Buy
649,775
+9,700
+2% +$4.08K ﹤0.01% 3948
2014
Q4
$282K Buy
640,075
+14,700
+2% +$6.48K ﹤0.01% 3845
2014
Q3
$206K Buy
625,375
+1,800
+0.3% +$593 ﹤0.01% 3887
2014
Q2
$331K Buy
623,575
+256,244
+70% +$136K ﹤0.01% 3770
2014
Q1
$239K Buy
367,331
+13,300
+4% +$8.65K ﹤0.01% 3793
2013
Q4
$223K Buy
354,031
+44,161
+14% +$27.8K ﹤0.01% 3746
2013
Q3
$107K Buy
309,870
+19,681
+7% +$6.8K ﹤0.01% 3766
2013
Q2
$119K Buy
+290,189
New +$119K ﹤0.01% 3712